291 related articles for article (PubMed ID: 17373924)
1. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
[TBL] [Abstract][Full Text] [Related]
6. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
Anandh U; Thomas PP; Shastry JC; Jacob CK
J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
[TBL] [Abstract][Full Text] [Related]
7. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
Sorkhi H; Dooki MR; Ebrahimnejad MS
J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
[TBL] [Abstract][Full Text] [Related]
8. Intradermal versus intramuscular hepatitis b re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation.
Fabrizi F; Andrulli S; Bacchini G; Corti M; Locatelli F
Nephrol Dial Transplant; 1997 Jun; 12(6):1204-11. PubMed ID: 9198052
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
McNulty CA; Bowen JK; Williams AJ
Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of intradermal and intramuscular vaccination against hepatitis B virus in incident chronic hemodialysis patients.
Charest AF; McDougall J; Goldstein MB
Am J Kidney Dis; 2000 Nov; 36(5):976-82. PubMed ID: 11054354
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure.
Agarwal SK; Irshad M; Dash SC
J Assoc Physicians India; 1999 Feb; 47(2):183-5. PubMed ID: 10999085
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and long-term immunogenicity of hepatitis B vaccine in haemodialysis patients.
Ramezani A; Eslamifar A; Banifazl M; Ahmadi F; Maziar S; Razeghi E; Kalantar E; Amirkhani A; Aghakhani A
Int J Clin Pract; 2009 Mar; 63(3):394-7. PubMed ID: 18005039
[TBL] [Abstract][Full Text] [Related]
13. Primary high-dose intradermal hepatitis B vaccination in hemodialysis: cost-effectiveness evaluation at 2 years.
Mat O; Mestrez F; Beauwens R; Muniz-Martinez MC; Dhaene M
Hemodial Int; 2006 Jan; 10(1):49-55. PubMed ID: 16441827
[TBL] [Abstract][Full Text] [Related]
14. Immune response of intradermal hepatitis B vaccination at lower dose versus intramuscular vaccination at double standard dose in predialytic chronic renal failure patients.
Somboonsilp W; Eiam-Ong S; Tungsanga K; Tirawatanapong T
J Med Assoc Thai; 2003 Dec; 86(12):1122-7. PubMed ID: 14971519
[TBL] [Abstract][Full Text] [Related]
15. Adjuvanted hepatitis B vaccine: new drug. Patients with renal failure: similar response rate but fewer boosters needed.
Prescrire Int; 2008 Dec; 17(98):234-6. PubMed ID: 19422145
[TBL] [Abstract][Full Text] [Related]
16. Clinical experience with a new recombinant hepatitis-B vaccine in previous non-responders with chronic renal insufficiency.
Haubitz M; Ehlerding G; Beigel A; Heuer U; Hemmerling AE; Thoma HA
Clin Nephrol; 1996 Mar; 45(3):180-2. PubMed ID: 8706359
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B vaccination in haemodialysis patients: a randomized clinical trial.
Bock M; Barros E; Veronese FJ
Nephrology (Carlton); 2009 Apr; 14(3):267-72. PubMed ID: 19207871
[TBL] [Abstract][Full Text] [Related]
19. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
[TBL] [Abstract][Full Text] [Related]
20. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
